Survival benefit of first-generation epidermal growth factor receptor-tyrosine kinase inhibitors in female with advanced lung cancer.
CONCLUSIONS:: Our analysis demonstrates that EGFR-TKIs confer significant PFS and OS benefits in the real-world practice for Korean female with advanced lung cancer.
PMID: 30905312 [PubMed - as supplied by publisher]
Source: Tumori - Category: Cancer & Oncology Tags: Tumori Source Type: research
More News: Alimta | Cancer | Cancer & Oncology | Chemotherapy | Databases & Libraries | Docetaxel | Health Insurance | Insurance | Lung Cancer | Study | Taxotere | Women